US Pharmaceutical Pfizer to apply for new corona vaccine approval during October 6:56 on September 4
U.S. pharmaceutical giant Pfizer announced that it will apply for approval and approval for use as early as next month if it determines that the new coronavirus vaccine under development is effective in the final clinical trial Did.
US pharmaceutical giant Pfizer is developing a new coronavirus vaccine in collaboration with a German company and is currently in the final stages of clinical trials in the United States and Brazil.
For this vaccine, Pfizer's Bula CEO said on the 3rd, that there will be enough data to determine its safety and efficacy as early as next month.
Then, if it was judged to be effective, it immediately clarified the policy to apply for permission and approval of use to the regulatory authorities of each country such as the US FDA = Food and Drug Administration.
On the other hand, with concerns about political pressure to rush to apply for permits and approvals ahead of the US presidential elections in November, Burra said, “We are effective and safe. We will not apply for approval or approval until we make a decision."
NIH = Dr. Fauch of the National Institutes of Health, who is involved in the Trump administration's countermeasures against the new coronavirus, said in an interview with the American media that the supply of vaccines next month would be "not impossible but unlikely".
The US government is asking each state to prepare for the start of the vaccination in November, and there is interest at the time the vaccination begins.